Inorganic nanosystems for therapeutic delivery: status and prospects - PubMed
Review
Inorganic nanosystems for therapeutic delivery: status and prospects
Chang Soo Kim et al. Adv Drug Deliv Rev. 2013 Jan.
Abstract
Inorganic nanomaterials have an array of structural and physical properties that can be used in therapeutic delivery systems. The sizes, shapes, and surfaces of inorganic nanomaterials can be tailored to produce distinct interactions with biological systems both in vitro and in vivo. Nanoparticle cores can likewise be engineered to possess unique opticophysical properties, including upconversion, size-dependent absorbance/emission as well as magnetic properties such as superparamagnetism. These properties make inorganic nanomaterials as useful imaging agents for noninvasive diagnostics and remotely activated theragnostics. Taken together, these unique properties of inorganic nanomaterials make them promising delivery systems.
Copyright © 2012 Elsevier B.V. All rights reserved.
Figures

Schematic presentation of inorganic nanomaterials with different sizes and shapes. The inorganic nanomaterials possess various physical, chemical properties and may be used in numerous applications in imaging, delivery, and theragnostic applications.

(a) Schematic illustration of upconversion luminescence of NPs triplet–triplet annihilation - upconversion nanophosphors NPs (TTA-UCNP), and chemical structures of building blocks for TTA-UCNP. (b) Energy level diagram of sensitized TTA process. (Reproduced with permission from [8], copyright by the American Chemical Society).

Real-time intravital imaging of size-dependent QDs distribution in a SCID mouse bearing a Mu89 melanoma. (a) Multiphoton microscopy image of the distribution of NPs at 30 min. (b) Multiphoton microscopy images of distribution of the NPs in the same region as (a) at 120 min post-injection. (c) Penetration depth analysis at 60 min post-injection. (Reproduced with permission from [14], copyright by the John Wiley and Sons)

Block diagram of the combined ultrasound and photoacoustic imaging system (a), photoacoustic images (b,c) and ultrasound (d) of gelatin implants in mouse tissue ex vivo at various laser illumination wavelengths. The cells with targeted AuNPs (red), control cells (white), the cells mixed with mPEG-SH coated Au NPs (green), and NIR dye (blue) are shown on the ultrasound image (d). (Reproduced with permission from [24], copyright by the American Chemical Society)

(a) Structure of the diaminohexane-terminated AuNP and cucurbit[7]uril (CB[7]). (b) Activation of AuNP–NH2–CB[7] cytotoxicity by dethreading of CB[7] from the NP surface by 1-adamatylamine. (Reproduced with permission from [41], copyright by the Nature Publishing Group)

(a) Schematic presentation of targeting of doxorubicin (DOX) loaded magnetic upconversion oxide nanospheres (MUC-F-NR) to tumor cells assisted by an externally applied magnetic field (MF). (b) Tumor location intensity increases with 1 h magnetic field treatment. (c) The luminescence signal at 650 nm. (d) Changes in tumor volume of mice treated with saline, MUC-F-NR, DOX, and DOX loaded MUC-F-NR over 21 days in the absence and presence of MF. (Reproduced with permission from [46], copyright by the American Chemical Society)
Similar articles
-
Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ. Fadeel B, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):111-29. doi: 10.1002/wnan.1206. Epub 2013 Jan 17. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013. PMID: 23335558 Review.
-
Physical and biochemical insights on DNA structures in artificial and living systems.
Chen N, Li J, Song H, Chao J, Huang Q, Fan C. Chen N, et al. Acc Chem Res. 2014 Jun 17;47(6):1720-30. doi: 10.1021/ar400324n. Epub 2014 Mar 3. Acc Chem Res. 2014. PMID: 24588263
-
Advanced drug delivery nanosystems (aDDnSs): a mini-review.
Demetzos C, Pippa N. Demetzos C, et al. Drug Deliv. 2014 Jun;21(4):250-7. doi: 10.3109/10717544.2013.844745. Epub 2013 Oct 17. Drug Deliv. 2014. PMID: 24134707 Review.
-
Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications.
Uddin I, Venkatachalam S, Mukhopadhyay A, Usmani MA. Uddin I, et al. Curr Pharm Des. 2016;22(11):1472-84. doi: 10.2174/1381612822666160118104727. Curr Pharm Des. 2016. PMID: 26775674 Review.
-
DNA nanomaterials for preclinical imaging and drug delivery.
Jiang D, England CG, Cai W. Jiang D, et al. J Control Release. 2016 Oct 10;239:27-38. doi: 10.1016/j.jconrel.2016.08.013. Epub 2016 Aug 13. J Control Release. 2016. PMID: 27527555 Free PMC article. Review.
Cited by
-
Advancement in Biopolymer Assisted Cancer Theranostics.
Bhattacharya T, Preetam S, Ghosh B, Chakrabarti T, Chakrabarti P, Samal SK, Thorat N. Bhattacharya T, et al. ACS Appl Bio Mater. 2023 Oct 16;6(10):3959-3983. doi: 10.1021/acsabm.3c00458. Epub 2023 Sep 12. ACS Appl Bio Mater. 2023. PMID: 37699558 Free PMC article. Review.
-
Cheng L, Kamkaew A, Sun H, Jiang D, Valdovinos HF, Gong H, England CG, Goel S, Barnhart TE, Cai W. Cheng L, et al. ACS Nano. 2016 Aug 23;10(8):7721-30. doi: 10.1021/acsnano.6b03074. Epub 2016 Jul 28. ACS Nano. 2016. PMID: 27459277 Free PMC article.
-
Hyperthermia-Triggered Gemcitabine Release from Polymer-Coated Magnetite Nanoparticles.
Iglesias GR, Reyes-Ortega F, Checa Fernandez BL, Delgado ÁV. Iglesias GR, et al. Polymers (Basel). 2018 Mar 6;10(3):269. doi: 10.3390/polym10030269. Polymers (Basel). 2018. PMID: 30966304 Free PMC article.
-
Li A, Xu D, Lin H, Yang S, Shao Y, Zhang Y. Li A, et al. Sci Rep. 2016 Aug 10;6:31366. doi: 10.1038/srep31366. Sci Rep. 2016. PMID: 27506629 Free PMC article.
-
Nair AB, Telsang M, Osmani RA. Nair AB, et al. Polymers (Basel). 2021 Oct 20;13(21):3623. doi: 10.3390/polym13213623. Polymers (Basel). 2021. PMID: 34771179 Free PMC article.
References
-
- Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010;9:615–627. - PubMed
-
- Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 2012;41:2885–2911. - PubMed
-
- Irrera A, Artoni P, Iacona F, Pecora EF, Franzo G, Galli M, Fazio B, Boninelli S, Priolo F. Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique. Nanotechnology. 2012;23:075204. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical